Welcome to the international HTA database
Showing [22164 Records] Selected Records [0 Hits] [Clear]
Year | Source | Title | |
---|---|---|---|
2014 | Unidad de Evaluacion de Tecnologias Sanitarias (UETS) | [Evaluation of efficiency of organizational models for stroke management (stroke units)] | |
2014 | Unidad de Evaluacion de Tecnologias Sanitarias (UETS) | [Surgery guided by imaging assessment: efficacy, safety and economic impact of intraoperative magnetic resonance imaging (update)] | |
2014 | Unidad de Evaluacion de Tecnologias Sanitarias (UETS) | [Economic evaluation of preimplantation genetic diagnosis (PGD) for screening] | |
2014 | Unidad de Evaluacion de Tecnologias Sanitarias (UETS) | [Assessment of effectiveness and safety of Cyberknife and Gamma knife radiosurgery in intra and extracraneal lesions' treatment (update)] | |
2013 | Unidad de Evaluacion de Tecnologias Sanitarias (UETS) | [Economic evaluation of drug eluting stents in the treatment of ischemic heart disease (update)] | |
2014 | Unidad de Evaluacion de Tecnologias Sanitarias (UETS) | [Cost effectiveness of different types of coronary stents which are used in patients with acute coronary syndrome (ACS)] | |
2010 | Unidad de Evaluacion de Tecnologias Sanitarias (UETS) | [Efficacy, safety and economic assessment of the percutaneous aortic valve implantation] | |
2010 | Unidad de Evaluacion de Tecnologias Sanitarias (UETS) | [Standards for the appropriate use of health technologies: diagnostic colonoscopy ] | |
2010 | Unidad de Evaluacion de Tecnologias Sanitarias (UETS) | [Economic evaluation of photoselective vaporization treatment for benign prostatic hyperplasia] | |
2010 | Unidad de Evaluacion de Tecnologias Sanitarias (UETS) | [Patient decision aids tool for breast cancer] | |
2010 | Unidad de Evaluacion de Tecnologias Sanitarias (UETS) | [Systematic review of the effectiveness of the stereoscopic vision systems for minimally invasive surgery] | |
2010 | Unidad de Evaluacion de Tecnologias Sanitarias (UETS) | [Systematic review of efficacy and economic impact of genetic tests in breast cancer and depression treatment] | |
2010 | Unidad de Evaluacion de Tecnologias Sanitarias (UETS) | [Key factors in Electronic Clinical Guides: Breast Cancer] | |
2003 | Unidad de Evaluacion de Tecnologias Sanitarias (UETS) | Efficacy, effectiveness and safety of drug eluting stents | |
2003 | Unidad de Evaluacion de Tecnologias Sanitarias (UETS) | Effectiveness and safety of cryosurgery for prostate cancer | |
2003 | Unidad de Evaluacion de Tecnologias Sanitarias (UETS) | Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus: indications | |
2003 | Unidad de Evaluacion de Tecnologias Sanitarias (UETS) | Botulinum toxin: indications, costs, and situation in other communities in Spain | |
1999 | Unidad De Tecnologias De Salud (ETESA) | Rational use of colloid solutions. Part I | |
2007 | Unit of Health Economics and Technology Assessment in Health Care (HunHTA) | [Infliximab in patients with arthritis psoriatic: systematic review of the clinical and economic literature] | |
2007 | Unit of Health Economics and Technology Assessment in Health Care (HunHTA) | [Parenteral methotrexate in patients with rheumatoid arthritis: systematic review, crossectional study and economic evaluation] | |
2007 | Unit of Health Economics and Technology Assessment in Health Care (HunHTA) | [Economic evaluation of the first TNF-alpha inhibitor therapy in patients with rheumatoid arthritis] | |
2007 | Unit of Health Economics and Technology Assessment in Health Care (HunHTA) | [Abatacept in the treatment of rheumatoid arthritis; systematic review and economic evaluation] | |
2001 | Unit of Health Economics and Technology Assessment in Health Care (HunHTA) | Breast and gynaecological cancer screening in Hungary: Cost effectiveness analysis, (in: Dorossy L, Organised screening in oncology; Guidebook in quality improvement and methodology) | |
2006 | Unit of Health Economics and Technology Assessment in Health Care (HunHTA) | [Rituximab in patients with rheumatoid arthritis:systematic review and economic evaluation] | |
2006 | Unit of Health Economics and Technology Assessment in Health Care (HunHTA) | [Etanercept in patients with juvenile idiopathic arthritis: systematic review and economic evaluation] | |
2006 | Unit of Health Economics and Technology Assessment in Health Care (HunHTA) | [Biologicals in patients with spondylitis ankylopoetica; the (REMICADE) therapy] | |
2006 | Unit of Health Economics and Technology Assessment in Health Care (HunHTA) | [Paclitaxel-Eluting Coronary Stent System in cardiovascular treatment; systematic review of the clinical and economic literature] | |
2006 | Unit of Health Economics and Technology Assessment in Health Care (HunHTA) | [Health economics modelling: costs, effectiveness and cost-effectiveness of biological agents in rheumatoid arthritis with particular emphasis on infliximab (REMICADE) therapy] | |
2005 | Unit of Health Economics and Technology Assessment in Health Care (HunHTA) | [Clinical effectiveness of carvedilol in comparison to -blockers, systematic review of the clinical and economic literature] | |
2005 | Unit of Health Economics and Technology Assessment in Health Care (HunHTA) | [Biologicals in patients with psoriasis, infliximab (REMICADE) therapy] | |
2005 | Unit of Health Economics and Technology Assessment in Health Care (HunHTA) | [Clinical effectiveness of indapamide; systematic review of the clinical and economic literature] | |
2002 | Unit of Health Economics and Technology Assessment in Health Care (HunHTA) | [DMARD therapy of rheumatoid arthritis, systematic review of the clinical and economic literature] | |
2003 | Unit of Health Economics and Technology Assessment in Health Care (HunHTA) | [Epidemiology and costs of osteoarthritis and rheumatoid arthritis in Hungary] | |
2004 | Unit of Health Economics and Technology Assessment in Health Care (HunHTA) | [The most often used androgen receptor blockers (flutamide, bicalutamide, nilutamide) in prostate cancer; systematic review of the clinical and economic literature] | |
2004 | Unit of Health Economics and Technology Assessment in Health Care (HunHTA) | [Infliximab (REMICADE) in patients with rheumatoid arthritis; systematic review of the clinical and economic literature] | |
2001 | University HealthSystem Consortium (UHC) | Tegaserod (Zelmac) (irritable bowel syndrome) | |
2001 | University HealthSystem Consortium (UHC) | Parenteral radiopaque contrast media | |
2005 | University HealthSystem Consortium (UHC) | Absorbable hemostatic agents | |
2005 | University HealthSystem Consortium (UHC) | Alvimopan | |
2005 | University HealthSystem Consortium (UHC) | Drotrecogin update | |
2005 | University HealthSystem Consortium (UHC) | Eszopiclone | |
2005 | University HealthSystem Consortium (UHC) | Exenatide | |
2005 | University HealthSystem Consortium (UHC) | Fluoroquinolones update | |
2005 | University HealthSystem Consortium (UHC) | HMG-CoA reductase inhibitors | |
2005 | University HealthSystem Consortium (UHC) | Inhaled anesthetic agents | |
2005 | University HealthSystem Consortium (UHC) | Low-molecular weight heparins update | |
2005 | University HealthSystem Consortium (UHC) | Lung surfactants update | |
2005 | University HealthSystem Consortium (UHC) | Natalizumab | |
2005 | University HealthSystem Consortium (UHC) | Neuromuscular blocking agents update | |
2005 | University HealthSystem Consortium (UHC) | Palifermin | |
2005 | University HealthSystem Consortium (UHC) | Pramlintide acetate | |
2005 | University HealthSystem Consortium (UHC) | Prasterone | |
2004 | University HealthSystem Consortium (UHC) | 5-HT3 antagonist update (2004) | |
2004 | University HealthSystem Consortium (UHC) | ACE inhibitors update | |
2004 | University HealthSystem Consortium (UHC) | Agents for multiple sclerosis (TCR) | |
2004 | University HealthSystem Consortium (UHC) | Aromatase inhibitors (TCR) | |
2004 | University HealthSystem Consortium (UHC) | Biologic agents for psoriasis | |
2004 | University HealthSystem Consortium (UHC) | Cinacalcet hydrochloride | |
2004 | University HealthSystem Consortium (UHC) | Daptomycin | |
2004 | University HealthSystem Consortium (UHC) | Gadolinium based contrast media | |
2004 | University HealthSystem Consortium (UHC) | Iodinated radiocontrast agents | |
2004 | University HealthSystem Consortium (UHC) | Levalbuterol hydrochloride update | |
2004 | University HealthSystem Consortium (UHC) | Memantine | |
2004 | University HealthSystem Consortium (UHC) | Oblimersen sodium (Genasense) | |
2004 | University HealthSystem Consortium (UHC) | Oregovomab | |
2004 | University HealthSystem Consortium (UHC) | Rasagiline | |
2003 | University HealthSystem Consortium (UHC) | Adefovir dipivoxil for treatment of hepatitis B | |
2003 | University HealthSystem Consortium (UHC) | Agents for pulmonary hypertension (TCR) | |
2003 | University HealthSystem Consortium (UHC) | Aripiprazole | |
2003 | University HealthSystem Consortium (UHC) | Atypical antipsychotics - update (TCR) | |
2003 | University HealthSystem Consortium (UHC) | Bortezomib | |
2003 | University HealthSystem Consortium (UHC) | Carbapenems | |
2003 | University HealthSystem Consortium (UHC) | Enfuvirtide | |
2003 | University HealthSystem Consortium (UHC) | Eplerenone | |
2003 | University HealthSystem Consortium (UHC) | Gene therapy | |
2003 | University HealthSystem Consortium (UHC) | HMG-CoA reductase inhibitors | |
2003 | University HealthSystem Consortium (UHC) | Immune globulin intravenous (IGIV) (TCR) | |
2003 | University HealthSystem Consortium (UHC) | Inhaled insulins (TCR) | |
2003 | University HealthSystem Consortium (UHC) | Oral and intravenous antifungal agents - update (TCR) | |
2003 | University HealthSystem Consortium (UHC) | Oxaliplatin | |
2003 | University HealthSystem Consortium (UHC) | Ranolazine | |
2003 | University HealthSystem Consortium (UHC) | Zevalin | |
2001 | University HealthSystem Consortium (UHC) | Smoking cessation therapies | |
2001 | University HealthSystem Consortium (UHC) | Proton pump inhibitors update | |
2001 | University HealthSystem Consortium (UHC) | Fluoroquinolones update | |
2001 | University HealthSystem Consortium (UHC) | Drotrecogin alfa | |
2001 | University HealthSystem Consortium (UHC) | Options for osteoporosis | |
2001 | University HealthSystem Consortium (UHC) | Oxcarbazepine | |
2001 | University HealthSystem Consortium (UHC) | SSRIs | |
2001 | University HealthSystem Consortium (UHC) | Antiparkinson agents | |
2001 | University HealthSystem Consortium (UHC) | Lung surfactants update | |
2001 | University HealthSystem Consortium (UHC) | Argatroban | |
2001 | University HealthSystem Consortium (UHC) | Novel erythropoiesis stimulating protein | |
2001 | University HealthSystem Consortium (UHC) | Glycoprotein IIb/IIIa receptor antagonists revised | |
2001 | University HealthSystem Consortium (UHC) | 5-HT3 antagonists update | |
2001 | University HealthSystem Consortium (UHC) | Hormone replacement therapy options | |
2001 | University HealthSystem Consortium (UHC) | Omapatrilat | |
2001 | University HealthSystem Consortium (UHC) | Liposomal amphotericin update | |
2002 | University HealthSystem Consortium (UHC) | Sedative/hypnotics | |
2002 | University HealthSystem Consortium (UHC) | Alzheimer's |